低剂量的化剂不会损害用于冷保存的人类卵巢组织
Lara Houeis1, Graziella van der Plancke1, Catherine Poirot2
1Gynecology Research Unit, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Fertility and sterility
|December 19, 2024
概括
低剂量化疗没有显著影响人类卵巢皮层组织的活力或密度. 之前的化疗暴露不应排除卵巢组织的冷保存以保护生育能力.
科学领域:
- 生殖生物学和瘤学.
- 卵巢组织的冷保存和移植.
背景情况:
- 化剂通常用于化疗方案.
- 化疗剂量对卵巢皮层的非激素毒性影响需要进一步研究.
- 卵巢组织冷保存是癌症患者的生育保存方法.
研究的目的:
- 为了评估基化剂的非冈纳多毒剂对人类卵巢皮层的影响.
- 评估之前的化疗暴露是否禁忌卵巢组织冷保存.
主要方法:
- 78例患者活检 (42例化疗暴露,36例对照) 的回顾性分析.
- 评估毛囊数量,形态,亡,激活,纤维化和血管化的情况.
- 免疫组织化学染色用于切割的caspase-3 (亡) 和-Akt (激活).
主要成果:
- 在化疗暴露和对照组之间没有观察到毛囊密度或活力的显著差异.
- 在化疗组中,观察到更高比例的非生长毛囊和增加的毛囊激活.
- 在暴露于化疗的成年患者中发现的二次毛囊数量显著减少;在青春期前的病例中观察到非典型的毛囊.
结论:
- 化剂的非纳毒剂剂似乎对卵巢组织质量有有限的影响.
- 在冷保存之前暴露于化疗的卵巢组织与未暴露的组织相似.
- 以前的化疗不应该是卵巢组织冷保存的禁忌.
相关概念视频
Meiosis II
183.2K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
183.2K
Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K


